Suppr
超能文献

A new era for cancer immunotherapy based on the genes that encode cancer antigens.

作者信息

Rosenberg S A

机构信息

Surgery Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Immunity. 1999 Mar;10(3):281-7. doi: 10.1016/s1074-7613(00)80028-x.

DOI:10.1016/s1074-7613(00)80028-x

PMID:10204484

Abstract

摘要

相似文献

A new era for cancer immunotherapy based on the genes that encode cancer antigens.

Immunity. 1999 Mar;10(3):281-7. doi: 10.1016/s1074-7613(00)80028-x.

Rekindling cancer vaccines.

Nat Biotechnol. 2016 Oct 11;34(10):1019-1024. doi: 10.1038/nbt.3690.

Cancer neoantigen: Boosting immunotherapy.

Biomed Pharmacother. 2020 Nov;131:110640. doi: 10.1016/j.biopha.2020.110640. Epub 2020 Aug 21.

Current status and future perspectives of dendritic cell-based cancer immunotherapy.

Scand J Immunol. 2013 Aug;78(2):167-71. doi: 10.1111/sji.12060.

A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.

Cancer Cytopathol. 2014 Jan;122(1):1-2. doi: 10.1002/cncy.21390.

Cancer vaccines: the state of the art.

Semin Immunol. 2010 Jun;22(3):103-4.

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.

Oncology (Williston Park). 2015 Dec;29(12):970-2, 974-5.

DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.

Pharmacol Ther. 2016 Sep;165:32-49. doi: 10.1016/j.pharmthera.2016.05.004. Epub 2016 May 24.

[Oncoimmunology: some fundamental problems of cancer immunotherapy].

Mol Biol (Mosk). 2007 Mar-Apr;41(2):355-68.

Cancer vaccines based on the identification of genes encoding cancer regression antigens.

Immunol Today. 1997 Apr;18(4):175-82. doi: 10.1016/s0167-5699(97)84664-6.

引用本文的文献

From foes to friends: rethinking the role of lymph nodes in prostate cancer.

Nat Rev Urol. 2024 Nov;21(11):687-700. doi: 10.1038/s41585-024-00912-9. Epub 2024 Aug 2.

Cancer stem cells: advances in knowledge and implications for cancer therapy.

Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation.

Int J Mol Sci. 2024 Mar 25;25(7):3660. doi: 10.3390/ijms25073660.

Modification of the tumor microenvironment enhances immunity with plasmid gene therapy.

Cancer Gene Ther. 2024 Apr;31(4):641-648. doi: 10.1038/s41417-024-00728-0. Epub 2024 Feb 9.

From mucosal infection to successful cancer immunotherapy.

Nat Rev Urol. 2023 Nov;20(11):682-700. doi: 10.1038/s41585-023-00784-5. Epub 2023 Jul 11.

A retrospective investigation of the relationship between neuroblastoma response to anti-GD2 monoclonal antibodies and exposure to opioids for pain management.

Pediatr Blood Cancer. 2023 Feb;70(2):e30069. doi: 10.1002/pbc.30069. Epub 2022 Oct 29.

Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation.

Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2203410119. doi: 10.1073/pnas.2203410119. Epub 2022 Jul 25.

Curcumin as an Adjuvant to Cancer Immunotherapy.

Front Oncol. 2021 Aug 16;11:675923. doi: 10.3389/fonc.2021.675923. eCollection 2021.

Prospects and Challenges for T Cell-Based Therapies of HCC.

Cells. 2021 Jun 30;10(7):1651. doi: 10.3390/cells10071651.

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies.

Oncoimmunology. 2021 Jan 7;10(1):1869389. doi: 10.1080/2162402X.2020.1869389.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A new era for cancer immunotherapy based on the genes that encode cancer antigens.

Immunity. 1999 Mar;10(3):281-7. doi: 10.1016/s1074-7613(00)80028-x.

Rekindling cancer vaccines.

Nat Biotechnol. 2016 Oct 11;34(10):1019-1024. doi: 10.1038/nbt.3690.

Cancer neoantigen: Boosting immunotherapy.

Biomed Pharmacother. 2020 Nov;131:110640. doi: 10.1016/j.biopha.2020.110640. Epub 2020 Aug 21.

Current status and future perspectives of dendritic cell-based cancer immunotherapy.

Scand J Immunol. 2013 Aug;78(2):167-71. doi: 10.1111/sji.12060.

A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.

Cancer Cytopathol. 2014 Jan;122(1):1-2. doi: 10.1002/cncy.21390.

Cancer vaccines: the state of the art.

Semin Immunol. 2010 Jun;22(3):103-4.

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.

Oncology (Williston Park). 2015 Dec;29(12):970-2, 974-5.

DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.

Pharmacol Ther. 2016 Sep;165:32-49. doi: 10.1016/j.pharmthera.2016.05.004. Epub 2016 May 24.

[Oncoimmunology: some fundamental problems of cancer immunotherapy].

Mol Biol (Mosk). 2007 Mar-Apr;41(2):355-68.

Cancer vaccines based on the identification of genes encoding cancer regression antigens.

Immunol Today. 1997 Apr;18(4):175-82. doi: 10.1016/s0167-5699(97)84664-6.

引用本文的文献

From foes to friends: rethinking the role of lymph nodes in prostate cancer.

Nat Rev Urol. 2024 Nov;21(11):687-700. doi: 10.1038/s41585-024-00912-9. Epub 2024 Aug 2.

Cancer stem cells: advances in knowledge and implications for cancer therapy.

Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation.

Int J Mol Sci. 2024 Mar 25;25(7):3660. doi: 10.3390/ijms25073660.

Modification of the tumor microenvironment enhances immunity with plasmid gene therapy.

Cancer Gene Ther. 2024 Apr;31(4):641-648. doi: 10.1038/s41417-024-00728-0. Epub 2024 Feb 9.

From mucosal infection to successful cancer immunotherapy.

Nat Rev Urol. 2023 Nov;20(11):682-700. doi: 10.1038/s41585-023-00784-5. Epub 2023 Jul 11.

A retrospective investigation of the relationship between neuroblastoma response to anti-GD2 monoclonal antibodies and exposure to opioids for pain management.

Pediatr Blood Cancer. 2023 Feb;70(2):e30069. doi: 10.1002/pbc.30069. Epub 2022 Oct 29.

Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation.

Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2203410119. doi: 10.1073/pnas.2203410119. Epub 2022 Jul 25.

Curcumin as an Adjuvant to Cancer Immunotherapy.

Front Oncol. 2021 Aug 16;11:675923. doi: 10.3389/fonc.2021.675923. eCollection 2021.

Prospects and Challenges for T Cell-Based Therapies of HCC.

Cells. 2021 Jun 30;10(7):1651. doi: 10.3390/cells10071651.

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies.

Oncoimmunology. 2021 Jan 7;10(1):1869389. doi: 10.1080/2162402X.2020.1869389.

Suppr超能文献

A new era for cancer immunotherapy based on the genes that encode cancer antigens.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译